Odonate Therapeutics, Inc. Company Profile & Data: stocks, market cap, financials, digital and more

                        
Company
Odonate Therapeutics, Inc.Headquarters: San Diego, 
                        CA, United States
                    
Employees: 137
CEO: Mr. Kevin C. Tang

                                    NASDAQ: ODT
                                
                                            -0.65%
                                            
Market Cap$43.1 Million

                        USD as of June 1, 2022
                    
                            Market Cap History

Odonate Therapeutics, Inc. Categories

United States Healthcare Biotechnology
United States Healthcare United States Biotechnology

Odonate Therapeutics, Inc. market capitalization over time

Evolution of Odonate Therapeutics, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Odonate Therapeutics, Inc.

Top Competitors by Market Capitalization

Industry: Biotechnology

Company	Market Cap (USD)
Novo Nordisk	$461.52 B
Vertex Pharmaceuticals Incorporated	$107.23 B
Regeneron Pharmaceuticals, Inc.	$100.01 B
CSL Limited	$94.74 B
Marinomed Biotech AG	$73.23 B

Sector:

Company	Market Cap (USD)
Lilly	$586.39 B
UnitedHealth Group	$504.47 B
Novo Nordisk	$461.52 B
Johnson & Johnson	$387.50 B
Merck	$296.51 B

Detailed Description

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.

Tweets by Odonate Therapeutics, Inc.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE